# DESCRIPTION

## BACKGROUND OF THE INVENTION

- motivate AAV purification

## SUMMARY OF THE INVENTION

- introduce AAV gene therapy platform
- motivate chromatographic methods for AAV production
- describe optimized chromatography purification process
- summarize advantages of disclosed methods
- outline embodiments of high efficiency purification methods
- summarize purification method
- describe chromatography resin medium
- outline elution buffer solution composition
- detail contacting and elution steps
- describe optional steps: capturing, sterilizing, and buffer exchange
- outline regeneration of chromatography resin medium
- describe preferred method of purification
- summarize overall efficiency and purity of AAV particles

## DETAILED DESCRIPTION OF THE INVENTION

- motivate chromatography for AAV production
- describe advantages of chromatographic purification
- disclose high efficiency purification method
- describe variations of purification method
- describe regeneration of chromatography resin medium
- summarize benefits of invention
- describe chromatography resin medium
- discuss empty capsid copurification
- outline methods to reduce empty capsid content
- detail neutralization and washing steps
- describe chromatography resin medium packing and flow rates
- discuss elution and capturing of AAV particles
- outline additional steps and methods for AAV particle purification
- describe cell growth medium
- describe transfection step
- describe providing cell lysate
- describe purification steps
- describe regeneration of chromatography resin medium
- describe AAV particles
- discuss empty capsid copurification
- outline methods to reduce empty capsid content
- detail neutralization and washing steps
- describe chromatography resin medium and elution steps
- outline additional steps, including capturing and sterilizing elution volume fractions
- summarize preferred methods of high efficiency purification of AAV particles

### EXAMPLES

- demonstrate AAVX binding to multiple AAV serotypes
- purify AAV using AAVX affinity chromatography
- regenerate AAVX resin for re-use without loss of efficiency
- optimize purification protocol for high efficiency
- compare purity and bioactivity of AAVX-HPLC and iodixanol purified AAV
- evaluate in vivo bioactivity of AAVX-HPLC purified AAV

### AAV Production and Purification

- produce AAV vectors in HEK293 cells
- harvest and lyse cells
- purify AAV using HPLC
- optimize purification protocol
- analyze AAV purity and titer

### AAV In Vitro Studies

- infect HEK293 cells with AAV

### AAV In Vivo Studies

- inject AAV into mice and analyze transduction

### DNA and RNA Quantification

- quantify AAV copy number and GFP RNA expression

### Immunofluorescence and Image Analysis

- analyze GFP expression in tissues

### AAV Phylogenetic Analysis

- generate phylogeny of AAV capsids

### Statistical Analysis

- specify statistical methods

### Supplementary Protocol: Production of AAV Using Hyperflasks and AAVX Affinity Chromatography

- outline production timeline and requirements
- list required items and reagents for each step
- describe tissue culture and transfection procedures
- outline lysis and clarification procedures
- describe HPLC purification and buffer exchange procedures
- provide tips for HPLC purification, including temperature control, resin binding capacity, and elution conditions
- outline resin regeneration and maintenance procedures
- prepare HPLC machine and buffers
- prime inlets and purge pumps
- set up fraction collector and sample line
- adjust AAVX_HPLC_S1 protocol as necessary
- perform buffer exchange using Amicon Stirred Cell
- concentrate and filter AAV solution
- repeat filtration until desired dilution is achieved
- measure and record final AAV volume
- store AAV and prepare for titration
- troubleshoot low AAV yield
- identify HPLC purification issues
- troubleshoot buffer exchange issues
- provide starting checklist and HPLC run method

